Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 16440.56 -58.16 NIFTY 4881.70 -16.70
 

Glenmark Pharma Quarterly Results, Glenmark Pharma Financial Statement & Accounts

Glenmark Pharma

BSE: 532296  |  NSE: GLENMARK  |  ISIN: INE935A01035  |  Pharmaceuticals

Notes To The Accounts
Print/Copy to Excel :
« Previous Years  

Quarterly Results of Glenmark Pharma

------------------- in Rs. Cr. -------------------
Sep '08 Dec '08 Mar '09 Jun '09 Sep '09
Sales Turnover 226.03 244.55 191.38 220.10 236.10
Other Income 25.34 9.37 63.70 1.88 2.62
Total Income 251.37 253.92 255.08 221.98 238.71
Total Expenses 149.95 165.05 172.41 213.70 173.29
Operating Profit 76.08 79.50 18.97 6.40 62.81
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- -- --
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 101.42 88.87 82.67 8.28 65.43
Interest 15.93 24.24 5.47 1.98 7.42
PBDT 85.49 64.62 77.19 6.29 58.01
Depreciation 4.61 4.88 5.29 5.28 5.30
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 80.88 59.74 71.90 1.01 52.71
Tax 13.99 22.82 14.62 -4.21 -4.79
Net Profit 66.89 36.92 57.28 5.22 57.50
Prior Years Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share 2.67 1.47 2.29 0.21 2.13
Book Value -- -- -- -- --
Equity 25.02 25.05 25.05 25.06 26.96
Reserves -- -- -- -- --
Face Value 1.00 1.00 1.00 1.00 1.00
Source : Religare Technova
Explore Glenmark connections